We are thrilled to announce that we received a global award for exception achievement from the international awards program The Global Recognition Awards™. We couldn’t be prouder of our team…
Read More
What does it look like to be one of digital pathology’s biggest advocates without actually being digital yet? In this episode of PathPulse, host Bianca Collings sits down with Dr….
A summary of a panel presentation held at the Digital Diagnostic Summit 2025 meeting. The panel was led by Imogen Fitt, a Principal Analyst at Signify Research, alongside panelists Giovanni…
Pathology education has never had more options, or more noise. Whether you’re a medical student building your foundation, a resident preparing for boards, or a pathologist looking to stay current…
By Amilynne Eddington, Director of Laboratory Operations, Lumea Ask anyone who has spent time in an anatomic pathology lab, and they will tell you the same thing: prostate core biopsies…
Recognition places Lumea among elite global winners including Medtronic and Thermo Fisher Scientific in one of digital health’s most competitive annual programs LEHI, UT, UNITED STATES, May 14, 2026 /…
Abigail Diepeveen Senior Director of Growth & Digital Strategy Abigail Diepeveen is Senior Director of Growth & Digital Strategy at Lumea, where she has spent nearly a decade working at…
Pathology has remained largely static for over a century: tissue fixed on glass, glass mounted on a microscope stage, and a pathologist confined to a physical office. Digital pathology disrupts…
By Heather A. Hansen, PathA/HTL, and Mark Evans, PhD Abstract Problems during tissue fixation and processing can lead to suboptimal preservation and diagnostic errors despite protocol adherence. Common issues include…
White Paper: A Comprehensive Analysis of Core Length, Tissue Integrity, and Downstream Clinical Outcomes Executive Summary In urological oncology, the needle core biopsy serves as the fundamental gateway to diagnosis,…
